Kaiser Permanente and University of Michigan receive $10.5 million to advance AI tools for cardiovascular disease screening and emergency response.
Key Details
- 1American Heart Association awarded $10.5M to two research teams for AI projects in cardiovascular care.
- 2Kaiser Permanente's project will use AI to detect kidney and liver disease on echocardiograms and conduct a multi-center clinical trial.
- 3University of Michigan's project will develop AI-guided wearable sensors for improved CPR outcomes.
- 4Cardiovascular disease caused 19.41 million global deaths in 2021; over 400,000 cardiac arrest deaths occur yearly in the U.S.
- 5AI aims to improve health professional decision making and treatment effectiveness for leading causes of death.
Why It Matters
These grants support pioneering research integrating AI with medical imaging and sensing to enable earlier disease detection and more personalized emergency care. The projects have potential to transform outcomes for cardiovascular, kidney, and liver conditions, which together cause millions of deaths globally.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
AI Unlocks Hidden Brain Lesions in Multiple Sclerosis via MRI
AI-enabled image processing reveals invisible cortical lesions in MRI scans of MS patients, advancing diagnosis and research.